Isho Takamasa
In the realm of modern medical imaging, the use of radiopharmaceuticals has revolutionized our ability to diagnose and monitor various medical conditions. Among these powerful compounds, Fluorodeoxyglucose F18, often abbreviated as FDG, has emerged as a vital tool in the fields of nuclear medicine and Positron Emission Tomography (PET) imaging.